bf/NASDAQ:ADMA_icon.jpeg

NASDAQ:ADMA

ADMA Biologics, Inc.

  • Stock

USD

Last Close

9.06

17/05 20:00

Market Cap

1.15B

Beta: 0.91

Volume Today

3.63M

Avg: 2.30M

PE Ratio

−27.46

PFCF: −49.81

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.47M
-
1.69M
15.10%
2.58M
52.60%
4.23M
64.24%
8.82M
108.46%
15.62M
77.04%
35.84M
129.42%
67.30M
87.78%
103.13M
53.24%
144.00M
39.63%
168.09M
16.73%
average payables
1.88M
-
2.24M
19.12%
1.93M
13.85%
2.33M
20.31%
4.24M
82.39%
5.91M
39.31%
7.54M
27.52%
10.12M
34.32%
11.75M
16.07%
12.83M
9.17%
14.44M
12.59%
average receivables
19.56K
-
191.98K
881.70%
654.21K
240.77%
971.25K
48.46%
2.45M
152.16%
2.64M
7.64%
2.43M
7.78%
8.35M
243.60%
20.91M
150.28%
22.04M
5.42%
21.46M
2.62%
book value per share
3.30
-
0.65
80.42%
0.08
87.81%
-0.37
565.14%
1.76
580.32%
0.44
75.16%
0.48
10.16%
1.02
112.56%
1.01
1.27%
0.77
24.06%
0.00
99.92%
capex per share
-0.03
-
-0.25
730.45%
-0.00
99.00%
-0.01
141.22%
-0.12
1,835.18%
-0.05
60.33%
-0.07
51.24%
-0.15
110.64%
-0.10
34.48%
-0.07
27.37%
-0.00
99.97%
capex to depreciation
-0.93
-
-9.37
904.08%
-0.06
99.41%
-0.16
181.70%
-0.99
535.87%
-0.61
38.83%
-1.17
92.41%
-3.23
175.93%
-2.46
23.84%
-1.96
20.46%
-0.57
70.72%
capex to operating cash flow
0.02
-
0.16
774.76%
0.00
98.93%
0.00
137.62%
0.07
1,686.97%
0.03
53.44%
0.05
49.63%
0.12
149.39%
0.12
3.63%
0.23
94.42%
-0.54
331.92%
capex to revenue
-0.06
-
-0.39
512.68%
-0.00
99.08%
-0.01
89.56%
-0.12
1,607.66%
-0.12
4.93%
-0.13
5.27%
-0.30
132.09%
-0.17
44.62%
-0.09
45.91%
-0.02
79.54%
cash per share
4.45
-
2.35
47.19%
1.61
31.35%
1.26
21.99%
1.88
49.51%
0.50
73.25%
0.49
2.25%
0.65
31.88%
0.37
43.61%
0.44
19.46%
0.00
99.95%
days of inventory on hand
301.07
-
166.66
44.65%
291.71
75.04%
288.07
1.25%
158.05
45.14%
161.04
1.89%
490.29
204.46%
485.56
0.97%
570.70
17.53%
501.60
12.11%
372.83
25.67%
days payables outstanding
488.75
-
173.53
64.50%
176.75
1.86%
147.17
16.74%
74.10
49.65%
51.04
31.12%
84.77
66.08%
65.95
22.21%
56.87
13.76%
40.64
28.54%
33.77
16.91%
days sales outstanding
23.69
-
47.01
98.44%
34.85
25.86%
62.22
78.53%
29.92
51.91%
43.15
44.22%
114.44
165.19%
128.86
12.60%
36.73
71.50%
38.76
5.53%
debt to assets
0.16
-
0.55
246.42%
0.66
20.65%
0.86
28.95%
0.43
49.90%
0.50
16.12%
0.67
33.98%
0.47
29.46%
0.37
20.78%
0.44
18.97%
0.43
3.07%
debt to equity
0.24
-
2.49
958.95%
19.16
669.08%
-4.55
123.72%
1.15
125.25%
2.24
94.90%
3.23
44.61%
1.11
65.79%
0.73
34.13%
1.02
39.40%
1.05
2.92%
dividend yield
earnings yield
-0.30
-
-0.16
46.85%
-0.21
32.02%
-0.31
46.65%
-0.60
89.84%
-0.61
2.24%
-0.26
56.89%
-0.52
98.74%
-0.43
17.72%
-0.11
74.14%
-0.00
99.97%
enterprise value
29.87M
-
101.56M
240.03%
89.32M
12.06%
72.57M
18.75%
73.36M
1.09%
129.47M
76.49%
275.37M
112.69%
209.73M
23.84%
248.64M
18.55%
835.68M
236.10%
1.01T
121,055.56%
enterprise value over ebitda
-2.03
-
-6.32
211.76%
-5.95
5.77%
-4.32
27.45%
-1.97
54.31%
-2.28
15.59%
-6.88
201.84%
-3.27
52.42%
-4.30
31.18%
-21.30
395.73%
46.80K
219,869.66%
ev to operating cash flow
-2.74
-
-6.91
151.75%
-5.79
16.13%
-3.97
31.43%
-1.97
50.45%
-2.07
4.95%
-3.61
74.96%
-2.06
43.11%
-2.21
7.61%
-14.04
534.66%
115.05K
819,390.48%
ev to sales
9.74
-
17.17
76.33%
12.44
27.52%
6.81
45.30%
3.22
52.65%
7.62
136.50%
9.38
23.09%
4.97
47.06%
3.07
38.16%
5.42
76.57%
3.92K
72,194.84%
free cash flow per share
-1.70
-
-1.83
7.98%
-1.48
19.06%
-1.51
1.75%
-1.74
15.61%
-1.43
17.84%
-1.47
2.70%
-1.33
9.53%
-0.90
32.28%
-0.37
58.86%
0.00
100.00%
free cash flow yield
-0.22
-
-0.16
24.59%
-0.18
12.03%
-0.29
60.37%
-0.54
84.39%
-0.60
10.34%
-0.37
38.64%
-0.68
85.58%
-0.64
6.35%
-0.10
85.05%
0.00
100.00%
graham net net
2.99
-
0.19
93.61%
-0.35
284.40%
-0.79
123.37%
-0.67
14.78%
-0.80
18.79%
-0.83
3.96%
-0.15
82.05%
-0.00
99.05%
-0.08
5,898.46%
-0.00
99.81%
graham number
13.29
-
5.13
61.40%
1.75
65.90%
3.64
108.03%
8.70
139.10%
3.78
56.52%
3.37
10.85%
4.84
43.51%
3.71
23.36%
2.73
26.50%
0.00
99.95%
income quality
0.70
-
0.87
24.74%
0.86
1.90%
0.94
9.11%
0.85
9.01%
0.95
11.93%
1.58
65.53%
1.35
14.67%
1.57
16.47%
0.90
42.43%
-0.31
134.51%
intangibles to total assets
0
-
0
0
0
0.08
Infinity%
0.08
9.28%
0.05
37.91%
0.03
45.35%
0.02
33.83%
0.01
31.51%
0.01
6.12%
interest coverage
-24.33
-
-12.45
48.82%
-8.42
32.40%
-7.74
8.09%
-11.96
54.60%
-10.92
8.75%
-4.61
57.81%
-5.42
17.59%
-4.47
17.46%
-2.04
54.33%
-0.86
57.67%
interest debt per share
0.87
-
1.75
100.68%
1.69
3.53%
1.85
9.69%
2.17
16.96%
1.10
49.16%
1.72
56.65%
1.27
26.19%
0.83
34.72%
0.88
5.66%
0.00
99.94%
inventory turnover
1.21
-
2.19
80.65%
1.25
42.87%
1.27
1.26%
2.31
82.27%
2.27
1.86%
0.74
67.15%
0.75
0.98%
0.64
14.92%
0.73
13.78%
0.98
34.54%
invested capital
0.24
-
2.49
958.95%
19.16
669.08%
-4.55
123.72%
1.15
125.25%
2.24
94.90%
3.23
44.61%
1.11
65.79%
0.73
34.13%
1.02
39.40%
1.05
2.92%
market cap
50.94M
-
103.79M
103.74%
84.03M
19.04%
62.23M
25.95%
73.50M
18.11%
108.00M
46.95%
217.39M
101.29%
167.98M
22.73%
196.81M
17.16%
767.75M
290.11%
1.01T
131,762.12%
net current asset value
20.65M
-
2.87M
86.10%
-1.60M
155.87%
-6.49M
304.53%
-4.52M
30.31%
-24.58M
443.80%
-15.08M
38.65%
34.32M
327.61%
73.65M
114.62%
73.91M
0.36%
63.04M
14.72%
net debt to ebitda
1.43
-
0.14
90.30%
-0.35
354.27%
-0.62
74.61%
0.00
100.60%
-0.38
10,384.32%
-1.45
283.25%
-0.65
55.02%
-0.90
37.38%
-1.73
93.28%
4.16
340.54%
net income per share
-2.38
-
-1.81
23.89%
-1.73
4.62%
-1.61
6.96%
-1.91
19.02%
-1.45
23.88%
-1.05
27.85%
-1.02
3.11%
-0.61
40.50%
-0.43
28.85%
-0.00
99.97%
operating cash flow per share
-1.67
-
-1.58
5.06%
-1.48
6.43%
-1.50
1.51%
-1.63
8.29%
-1.39
14.79%
-1.40
1.08%
-1.18
15.54%
-0.81
32.01%
-0.30
62.64%
0.00
100.01%
payables turnover
0.75
-
2.10
181.66%
2.07
1.82%
2.48
20.10%
4.93
98.61%
7.15
45.18%
4.31
39.79%
5.53
28.54%
6.42
15.95%
8.98
39.94%
10.81
20.36%
receivables turnover
15.41
-
7.76
49.61%
10.47
34.88%
5.87
43.99%
12.20
107.95%
8.46
30.66%
3.19
62.29%
2.83
11.19%
9.94
250.84%
9.42
5.24%
research and ddevelopement to revenue
3.03
-
1.61
46.95%
0.98
39.24%
0.72
26.22%
0.27
62.05%
0.23
15.55%
0.08
65.45%
0.14
75.19%
0.05
67.80%
0.02
47.93%
0.01
45.51%
return on tangible assets
-0.49
-
-0.62
27.18%
-0.76
22.71%
-0.82
8.73%
-0.44
46.70%
-0.81
84.04%
-0.47
41.38%
-0.43
8.33%
-0.31
28.25%
-0.25
20.52%
-0.09
64.94%
revenue per share
0.47
-
0.64
35.54%
0.69
8.28%
0.88
27.25%
0.99
13.32%
0.38
62.19%
0.54
43.67%
0.49
9.24%
0.58
18.32%
0.78
34.28%
0.00
99.85%
roe
-0.72
-
-2.80
288.77%
-21.89
682.25%
4.38
120.00%
-1.08
124.78%
-3.33
206.50%
-2.18
34.51%
-0.99
54.42%
-0.60
39.74%
-0.56
6.30%
-0.21
62.74%
roic
-0.58
-
-0.74
26.98%
-1.06
44.11%
-1.22
14.56%
-0.50
58.91%
-1.02
103.60%
-0.44
57.24%
-0.39
9.51%
-0.27
30.71%
-0.16
41.37%
0.08
147.04%
sales general and administrative to revenue
1.42
-
0.82
42.70%
0.94
15.26%
0.80
15.22%
0.79
0.24%
1.32
66.66%
shareholders equity per share
3.30
-
0.65
80.42%
0.08
87.81%
-0.37
565.14%
1.76
580.32%
0.44
75.16%
0.48
10.16%
1.02
112.56%
1.01
1.27%
0.77
24.06%
0.00
99.92%
stock based compensation to revenue
0.29
-
0.21
27.12%
0.24
12.95%
0.12
50.81%
0.07
41.49%
0.13
90.77%
0.09
31.00%
0.07
25.13%
0.04
36.27%
0.03
21.47%
0.02
29.20%
tangible asset value
21.57M
-
6.01M
72.15%
820.97K
86.34%
-4.46M
642.92%
31.95M
816.90%
12.24M
61.71%
19.50M
59.39%
82.28M
321.84%
135.91M
65.19%
147.43M
8.47%
131.18M
11.02%
tangible book value per share
3.30
-
0.65
80.42%
0.08
87.81%
-0.37
565.14%
1.40
480.53%
0.27
80.60%
0.36
32.53%
0.96
166.13%
0.97
1.95%
0.75
23.48%
0.00
99.92%
working capital
27.39M
-
19.89M
27.39%
17.07M
14.16%
10.43M
38.89%
53.73M
414.90%
34.90M
35.03%
71.79M
105.68%
133.79M
86.36%
178.35M
33.30%
231.13M
29.60%
207.21M
10.35%

All numbers in USD (except ratios and percentages)